Lv11
50 积分 2024-03-30 加入
Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial
2小时前
已完结
Glycoprotein IIb/IIIa Inhibitors in Acute Myocardial Infarction and Angiographic Microvascular Obstruction: The REVERSE-FLOW Trial
8天前
已完结
Tirofiban for myocardial infarction
1个月前
已完结
State of the Art
1个月前
已完结
[2019 Chinese Society of Cardiology (CSC) guidelines for the diagnosis and management of patients with ST-segment elevation myocardial infarction]
1个月前
已完结
A Noncontrast CMR Risk Score for Long-Term Risk Stratification in Reperfused ST-Segment Elevation Myocardial Infarction
7个月前
已完结
Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart Association
7个月前
已完结
Comparison of intracoronary versus intravenous administration of tirofiban in primary percutaneous coronary intervention
7个月前
已完结
Comparison of intracoronary versus intravenous administration of tirofiban in primary percutaneous coronary intervention
7个月前
已完结
NT-proBNP level before primary PCI and risk of poor myocardial reperfusion: Insight from the On-TIME II trial
7个月前
已完结
皖公网安备34019202002308
